[PARENTE RANDOLPH LETTERHEAD]



                        INDEPENDENT ACCOUNTANTS' REPORT


We have reviewed the accompanying balance sheet of Mediscience  Technology Corp.
(the  "Company") as of May 31, 2000,  and the related  statement of  operations,
cash flows and stockholders' equity for the three-month period then ended. These
financial statements are the responsibility of the Company's management.


We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with auditing standards generally accepted in the United States of America,  the
objective  of which is the  expression  of an opinion  regarding  the  financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the  accompanying  financial  statements for them to be in conformity
with accounting principles generally accepted in the United States of America.

Certain  conditions  indicate  that the  Company  may be unable to continue as a
going  concern.  The  accompanying  financial  statements  do  not  include  any
adjustments  to the  financial  statements  that might be  necessary  should the
Company be unable to continue as a going concern.



                                                        /s/ Parente Randolph, PC
                                                        ------------------------
                                                        Parente Randolph, PC

Philadelphia, Pennsylvania
April 19, 2001